Project A phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of…

Basic data

Title:
A phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lamipalizumab administered intravitreally to patients with geographic atrophy secondary to age-related miacular degeneration
Duration:
01/04/2015 to 31/12/2018
Abstract / short description:
A phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lamipalizumab administered intravitreally to patients with geographic atrophy secondary to age-related miacular degeneration
Keywords:
LAMIPALIZUMAB
AMD
clinical trial
klinische Studie

Involved staff

Managers

Center for Ophthalmology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

University Eye Hospital
Center for Ophthalmology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Grenzach-Wyhlen, Baden-Württemberg, Germany
Help

will be deleted permanently. This cannot be undone.